 |
Active calcium sensing receptor antagonist derived from tetrahydropyrazolopyrimidine |
|---|---|
| Trade Name | |
| Orphan Indication | Pulmonary Arterial Hypertension |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-13 00:00:00 |
| Sponsor | Takeda Development Centre Europe, Ltd.;61 Aldwych;London |
